Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TGTX |
---|---|---|
09:32 ET | 219808 | 24.09 |
09:34 ET | 206009 | 24.01 |
09:36 ET | 123648 | 24.02 |
09:38 ET | 113055 | 24.16 |
09:39 ET | 178895 | 24.12 |
09:41 ET | 112432 | 23.9885 |
09:43 ET | 68481 | 24.12 |
09:45 ET | 48383 | 23.75 |
09:48 ET | 46245 | 23.72 |
09:50 ET | 26590 | 23.83 |
09:52 ET | 37659 | 23.71 |
09:54 ET | 44501 | 23.71 |
09:56 ET | 37324 | 23.8 |
09:57 ET | 23815 | 23.74 |
09:59 ET | 35995 | 23.62 |
10:01 ET | 130944 | 23.61 |
10:03 ET | 60160 | 23.582 |
10:06 ET | 34876 | 23.55 |
10:08 ET | 29173 | 23.6 |
10:10 ET | 27791 | 23.51 |
10:12 ET | 13785 | 23.56 |
10:14 ET | 27140 | 23.695 |
10:15 ET | 19240 | 23.71 |
10:17 ET | 29098 | 23.715 |
10:19 ET | 24676 | 23.7101 |
10:21 ET | 32195 | 23.72 |
10:24 ET | 80862 | 23.61 |
10:26 ET | 19741 | 23.675 |
10:28 ET | 72307 | 23.795 |
10:30 ET | 34712 | 23.68 |
10:32 ET | 35682 | 23.62 |
10:33 ET | 27960 | 23.47 |
10:35 ET | 19202 | 23.455 |
10:37 ET | 14447 | 23.47 |
10:39 ET | 13912 | 23.425 |
10:42 ET | 8397 | 23.3915 |
10:44 ET | 35802 | 23.32 |
10:46 ET | 11625 | 23.29 |
10:48 ET | 6979 | 23.27 |
10:50 ET | 9561 | 23.35 |
10:51 ET | 9338 | 23.33 |
10:53 ET | 10349 | 23.38 |
10:55 ET | 19796 | 23.36 |
10:57 ET | 5224 | 23.395 |
11:00 ET | 22062 | 23.42 |
11:02 ET | 14114 | 23.39 |
11:04 ET | 12435 | 23.44 |
11:06 ET | 18213 | 23.39 |
11:08 ET | 11327 | 23.365 |
11:09 ET | 17032 | 23.26 |
11:11 ET | 43444 | 23.205 |
11:13 ET | 23947 | 23.24 |
11:15 ET | 8279 | 23.235 |
11:18 ET | 7839 | 23.21 |
11:20 ET | 34140 | 23.09 |
11:22 ET | 6028 | 23.13 |
11:24 ET | 12443 | 23.15 |
11:26 ET | 8152 | 23.17 |
11:27 ET | 7686 | 23.25 |
11:29 ET | 11671 | 23.31 |
11:31 ET | 8181 | 23.28 |
11:33 ET | 10524 | 23.25 |
11:36 ET | 5375 | 23.28 |
11:38 ET | 14197 | 23.22 |
11:40 ET | 7676 | 23.17 |
11:42 ET | 8886 | 23.13 |
11:44 ET | 22580 | 23.06 |
11:45 ET | 33565 | 22.89 |
11:47 ET | 15025 | 22.85 |
11:49 ET | 96678 | 22.94 |
11:51 ET | 18237 | 23.12 |
11:54 ET | 33198 | 23.17 |
11:56 ET | 19621 | 23.11 |
11:58 ET | 12177 | 23.05 |
12:00 ET | 14335 | 23.01 |
12:02 ET | 12042 | 23.03 |
12:03 ET | 10708 | 22.99 |
12:05 ET | 10362 | 23.01 |
12:07 ET | 8017 | 23.04 |
12:09 ET | 13222 | 23.11 |
12:12 ET | 15374 | 23.11 |
12:14 ET | 4789 | 23.13 |
12:16 ET | 9013 | 23.1001 |
12:18 ET | 12602 | 23.13 |
12:20 ET | 5020 | 23.12 |
12:21 ET | 13984 | 23.05 |
12:23 ET | 6829 | 23.1 |
12:25 ET | 9677 | 23.12 |
12:27 ET | 8931 | 23.18 |
12:30 ET | 9044 | 23.155 |
12:32 ET | 3275 | 23.175 |
12:34 ET | 8068 | 23.24 |
12:36 ET | 20336 | 23.315 |
12:38 ET | 7141 | 23.34 |
12:39 ET | 14095 | 23.38 |
12:41 ET | 21461 | 23.43 |
12:43 ET | 7646 | 23.49 |
12:45 ET | 13301 | 23.4947 |
12:48 ET | 13860 | 23.48 |
12:50 ET | 3548 | 23.45 |
12:52 ET | 7707 | 23.46 |
12:54 ET | 4822 | 23.485 |
12:56 ET | 13783 | 23.49 |
12:57 ET | 5300 | 23.495 |
12:59 ET | 6234 | 23.475 |
01:01 ET | 6274 | 23.5 |
01:03 ET | 21089 | 23.52 |
01:06 ET | 3625 | 23.51 |
01:08 ET | 7872 | 23.49 |
01:10 ET | 8134 | 23.4699 |
01:12 ET | 3621 | 23.505 |
01:14 ET | 3040 | 23.51 |
01:15 ET | 5270 | 23.44 |
01:17 ET | 7324 | 23.45 |
01:19 ET | 1106 | 23.495 |
01:21 ET | 5768 | 23.5 |
01:24 ET | 2721 | 23.5 |
01:26 ET | 8581 | 23.49 |
01:28 ET | 4646 | 23.51 |
01:30 ET | 7517 | 23.53 |
01:32 ET | 14840 | 23.5205 |
01:33 ET | 9408 | 23.48 |
01:35 ET | 2671 | 23.47 |
01:37 ET | 4212 | 23.51 |
01:39 ET | 7482 | 23.5 |
01:42 ET | 6818 | 23.51 |
01:44 ET | 6626 | 23.48 |
01:46 ET | 6129 | 23.445 |
01:48 ET | 5037 | 23.49 |
01:50 ET | 34773 | 23.51 |
01:51 ET | 8267 | 23.51 |
01:53 ET | 16789 | 23.53 |
01:55 ET | 6875 | 23.51 |
01:57 ET | 8461 | 23.5 |
02:00 ET | 6255 | 23.47 |
02:02 ET | 6707 | 23.48 |
02:04 ET | 5893 | 23.475 |
02:06 ET | 4646 | 23.5 |
02:08 ET | 7094 | 23.51 |
02:09 ET | 10104 | 23.485 |
02:11 ET | 4230 | 23.495 |
02:13 ET | 11083 | 23.47 |
02:15 ET | 16323 | 23.47 |
02:18 ET | 7962 | 23.51 |
02:20 ET | 9732 | 23.53 |
02:22 ET | 7428 | 23.565 |
02:24 ET | 9620 | 23.57 |
02:26 ET | 14366 | 23.57 |
02:27 ET | 6297 | 23.565 |
02:29 ET | 4936 | 23.54 |
02:31 ET | 21351 | 23.49 |
02:33 ET | 10122 | 23.5 |
02:36 ET | 8694 | 23.46 |
02:38 ET | 4596 | 23.4799 |
02:40 ET | 4771 | 23.46 |
02:42 ET | 4696 | 23.46 |
02:44 ET | 8070 | 23.51 |
02:45 ET | 11425 | 23.58 |
02:47 ET | 11483 | 23.645 |
02:49 ET | 8299 | 23.74 |
02:51 ET | 26278 | 23.77 |
02:54 ET | 11527 | 23.81 |
02:56 ET | 22186 | 23.78 |
02:58 ET | 12402 | 23.67 |
03:00 ET | 11701 | 23.68 |
03:02 ET | 14158 | 23.73 |
03:03 ET | 13292 | 23.69 |
03:05 ET | 10028 | 23.67 |
03:07 ET | 11441 | 23.74 |
03:09 ET | 17456 | 23.78 |
03:12 ET | 17388 | 23.755 |
03:14 ET | 8826 | 23.745 |
03:16 ET | 8688 | 23.775 |
03:18 ET | 10247 | 23.805 |
03:20 ET | 16709 | 23.725 |
03:21 ET | 25955 | 23.555 |
03:23 ET | 22223 | 23.582 |
03:25 ET | 16342 | 23.77 |
03:27 ET | 10276 | 23.79 |
03:30 ET | 21673 | 23.69 |
03:32 ET | 14168 | 23.74 |
03:34 ET | 15931 | 23.715 |
03:36 ET | 19288 | 23.73 |
03:38 ET | 19275 | 23.76 |
03:39 ET | 16374 | 23.75 |
03:41 ET | 20864 | 23.8 |
03:43 ET | 21334 | 23.84 |
03:45 ET | 19325 | 23.8078 |
03:48 ET | 17089 | 23.8234 |
03:50 ET | 28083 | 23.795 |
03:52 ET | 33410 | 23.745 |
03:54 ET | 31282 | 23.7799 |
03:56 ET | 52676 | 23.81 |
03:57 ET | 86353 | 23.8 |
03:59 ET | 626987 | 23.75 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
TG Therapeutics Inc | 3.7B | 39.6x | --- |
Denali Therapeutics Inc | 3.7B | -9.0x | --- |
ADMA Biologics Inc | 4.3B | 130.7x | --- |
Arrowhead Pharmaceuticals Inc | 2.7B | -4.7x | --- |
CRISPR Therapeutics AG | 3.8B | -14.0x | --- |
Axsome Therapeutics Inc | 4.5B | -14.4x | --- |
TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. TG-1801 is a bispecific CD47 and CD19 antibody. It is the therapy to target both CD19, a B-cell specific market expressed across B-cell malignancies, and CD47. It also evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.7B |
---|---|
Revenue (TTM) | $346.7M |
Shares Outstanding | 154.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.20 |
EPS | $0.60 |
Book Value | $1.06 |
P/E Ratio | 39.6x |
Price/Sales (TTM) | 10.6 |
Price/Cash Flow (TTM) | 38.4x |
Operating Margin | 29.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.